February 2020: We are excited to have just received a funding notification for our recent R15 grant application! The NIH award is a 3-year $450,480 grant from the NIAID entitled “Cell-specific blockage of TLR activation: A new strategy for addressing inflammatory disorders.” The goal of this project is to develop targeted therapeutics that selectively inhibit the innate immune response through inhibition of a key enzyme in the TLR signaling pathway.
January 2020: Welcome to two new members of our group, Justin Howe and Katherine Leong. Both Justin and Katherine are sophomore chemistry students at BU.
December 2019: Five abstracts from our group were recently accepted for the upcoming national meeting of the American Chemical Society in Philadelphia! (link)